Noven Added To NASDAQ Neuroinsights Neurotech Index

-- Noven Pharmaceuticals, Inc. (NASDAQ: NOVN) announced today that it has been added to the NASDAQ® NeuroInsights® Neurotech Index (NASDAQ: NERV). The Neurotech Index is designed to track the performance of leading neurotechnology companies listed and actively traded on one of the three major U.S. stock exchanges.

The Neurotech Index includes companies engaged in researching, developing, manufacturing and marketing pharmaceuticals, biologics, medical devices and diagnostics for the brain and nervous system. In addition to meeting minimum market criteria, the companies included in the index must be identified by NeuroInsights as significantly involved in the neurotechnology industry, which includes treatments and diagnostics for disorders like Alzheimer’s, addiction, anxiety, depression, epilepsy, multiple sclerosis, obesity, pain, Parkinson’s, schizophrenia, sensory disorders, sleep disorders, stroke, and traumatic brain injury. Noven’s specialty pharmaceutical unit, Noven Therapeutics, markets and sells prescription products for the treatment of major depressive disorder, bipolar disorder and other psychiatric conditions.

About Noven
Noven Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in the research, development, manufacture, marketing and sale of prescription pharmaceutical products. Noven’s business and operations are focused in three principal areas – transdermal drug delivery, the Novogyne joint venture, and its Noven Therapeutics specialty pharmaceutical unit. For additional information, see www.noven.com.

About NeuroInsights
NeuroInsights is the world’s leading neurotechnology research and advisory firm. As the neurotechnology market authority, NeuroInsights helps investors, industry and society understand and profit from the rapid growth in drugs, devices and diagnostics for the brain and nervous system. NeuroInsights provides market reports, investment information, industry events and strategic advisory services to venture funds, startups, corporations, governments and financial institutions. For more information, visit www.neuroinsights.com.

About NASDAQ
NASDAQ is the largest U.S. equities exchange. With approximately 3,200 companies, it lists more companies and, on average, trades more shares per day than any other U.S. market. It is home to companies that are leaders across all areas of business including technology, retail, communications, financial services, transportation, media and biotechnology. NASDAQ is the primary market for trading NASDAQ-listed stocks as well as a leading liquidity pool for trading NYSE-listed stocks. For more information about NASDAQ, visit the NASDAQ Web site at www.nasdaq.com or the NASDAQ Newsroom at www.nasdaq.com/newsroom.

Contact:
Joseph C. Jones
Noven Pharmaceuticals, Inc.
Vice President – Corporate Affairs
305-253-1916